How to buy Bioxyne shares

Bioxyne Limited is a biotechnology business based in Australia. Bioxyne shares (BXN) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Bioxyne has a trailing 12-month revenue of around $2.3 million.

How to buy shares in Bioxyne

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Bioxyne. Find the share by name or ticker symbol: BXN. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Bioxyne reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Bioxyne. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Bioxyne share price

Use our graph to track the performance of BXN stocks over time.

Bioxyne shares at a glance

• Key figures

Information last updated 2020-09-25.

52-week range	AUDA$0.007 - AUDA$0.021
50-day moving average	AUDA$0.0131
200-day moving average	AUDA$0.0119
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.002

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Bioxyne stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Bioxyne Limited by TradingView

Bioxyne financials

Revenue TTM	$2.3 million
Gross profit TTM	$1.3 million
Return on assets TTM	-5.57%
Return on equity TTM	-20.63%
Profit margin	-25.55%
Book value	0.004
Market capitalisation	$7.7 million

TTM: trailing 12 months

Bioxyne share dividends

We're not expecting Bioxyne to pay a dividend over the next 12 months.

Have Bioxyne's shares ever split?

Bioxyne's shares were split on a 1:20 basis on 18 March 2012. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bioxyne shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Bioxyne shares which in turn could have impacted Bioxyne's share price.

Bioxyne share price volatility

Over the last 12 months, Bioxyne's shares have ranged in value from as little as $0.007 up to $0.021. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Bioxyne's is 2.0994. This would suggest that Bioxyne's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Bioxyne overview

Bioxyne Limited, a life sciences and health products company, researches, develops, manufactures, markets, and distributes consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. The company operates through Wholesale Sales and Direct Sales segments. It also engages in developing a range of functional foods and beauty products. The company's products portfolio include BK18, a dairy based food supplement; Allura, a beauty drink with soy protein and apple fibre, and marine collagen extract for women's weight management; Mustang, a nutritional shake for men's weight management; Mymana, a colostrum and honey based dairy formula product; and BEssence, an anti-ageing serum. In addition, it offers its probiotic products under the Progastrim and proTract names. The company provides its products online, as well as through retail channels in Australia, the United States, New Zealand, and Asia. Bioxyne Limited is incorporated in 1998 and is headquartered in Sydney, Australia.

Frequently asked questions

• What percentage of Bioxyne is owned by insiders?

  Currently 66.976% of Bioxyne shares are held by insiders.

• When does the fiscal year end for Bioxyne?

  Bioxyne's fiscal year ends in June.

• Where is Bioxyne based?

  Bioxyne's address is: 50 Clarence Street, Sydney, NSW, Australia, 2000

• What is Bioxyne's ISIN number?

  Bioxyne's international securities identification number is: AU000000BXN6